|
BG51486A1
|
|
Preparation for treatment of chronic respiratory insufficiency
|
|
BG51529A1
|
|
Hybridome cell line producting monoclonal antibody against h1-antigenous determinant of h1, 2-antigenous complex
|
|
BG51530A1
|
|
Hybridome cell line prodicing conoclonal antibody against h6-antigenous determinant of h1, 6-antigenous complex
|
|
BG51528A1
|
|
Nutrient medium for callus tissue induction and cultivation of fagopyrum (l.) gaertn., producing flavonoids
|
|
BG51387A1
|
|
Method for interferon induction
|
|
BG51400A1
|
|
N, n'- disubstituted carbamides and process for the preparation thereof
|
|
BG51385A1
|
|
Device for electropuncture
|
|
BG51279A1
|
|
Method for labelling apotransfereine with 65 zinc chloride
|
|
BG51278A1
|
|
Method for potentiation of the therapeutical effect of human recombination erythropoietin
|
|
BG51276A1
|
|
Method for treatment of pathological states of bonnes
|
|
BG51099A1
|
|
Adenosinephosphorus derivatives of 2'-deoxycytidine, method for their preparation and application
|
|
BG51098A1
|
|
Process for producing of radiosensibilizing compound
|
|
BG51097A1
|
|
Process for the preparation of radiosensibilizing agent
|
|
BG51001A1
|
|
METHOD FOR THE PRODUCTION OF MONOCLONAL ANTIBODY AGAINST Hh- ANTIGENOUS DETERMINANT OF Heh- ANTIGEN COMPLEX
|
|
BG51002A1
|
|
Method for the preparation of monoclonal antibody against 03- salmonellan antigen
|
|
BG50997A1
|
|
Method for the producing of radiosensibilizing substance
|
|
BG50993A1
|
|
2, 3, 5- three substituted oxazolydines and process for their preparation
|
|
BG93347A
|
|
Boiceramic root implant for closed implantation
|
|
BG50738A1
|
|
Method for the liquidation of direct bronchial fistulas
|
|
BG50991A1
|
|
N, n- bisubstituted derivatives of 5, 8- dimethoxy- 2- ureido- 3- hydroxy- 1, 2, 3, 4- tetrahydronaphthaline and the process for its preparation
|
